2IV9 image
Deposition Date 2006-06-08
Release Date 2007-03-13
Last Version Date 2023-12-13
Entry Detail
PDB ID:
2IV9
Title:
B2-appendage from AP2 in complex with Eps15 peptide
Biological Source:
Source Organism:
HOMO SAPIENS (Taxon ID: 9606)
RATTUS NORVEGICUS (Taxon ID: 10116)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.90 Å
R-Value Free:
0.26
R-Value Work:
0.21
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:AP-2 COMPLEX SUBUNIT BETA-2
Gene (Uniprot):AP2B1
Chain IDs:A, B
Chain Length:238
Number of Molecules:2
Biological Source:HOMO SAPIENS
Polymer Type:polypeptide(L)
Molecule:EPIDERMAL GROWTH FACTOR RECEPTOR SUBSTRATE 15 ISOFORM B
Chain IDs:C (auth: P)
Chain Length:12
Number of Molecules:1
Biological Source:RATTUS NORVEGICUS
Ligand Molecules
Primary Citation
Role of the Ap2 Beta-Appendage Hub in Recruiting Partners for Clathrin-Coated Vesicle Assembly
Plos Biol. 4 262 ? (2006)
PMID: 16903783 DOI: 10.1371/JOURNAL.PBIO.0040262

Abstact

Adaptor protein complex 2 alpha and beta-appendage domains act as hubs for the assembly of accessory protein networks involved in clathrin-coated vesicle formation. We identify a large repertoire of beta-appendage interactors by mass spectrometry. These interact with two distinct ligand interaction sites on the beta-appendage (the "top" and "side" sites) that bind motifs distinct from those previously identified on the alpha-appendage. We solved the structure of the beta-appendage with a peptide from the accessory protein Eps15 bound to the side site and with a peptide from the accessory cargo adaptor beta-arrestin bound to the top site. We show that accessory proteins can bind simultaneously to multiple appendages, allowing these to cooperate in enhancing ligand avidities that appear to be irreversible in vitro. We now propose that clathrin, which interacts with the beta-appendage, achieves ligand displacement in vivo by self-polymerisation as the coated pit matures. This changes the interaction environment from liquid-phase, affinity-driven interactions, to interactions driven by solid-phase stability ("matricity"). Accessory proteins that interact solely with the appendages are thereby displaced to areas of the coated pit where clathrin has not yet polymerised. However, proteins such as beta-arrestin (non-visual arrestin) and autosomal recessive hypercholesterolemia protein, which have direct clathrin interactions, will remain in the coated pits with their interacting receptors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures